Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detection

被引:59
作者
Rizzo, V
Porta, C
Moroni, M
Scoglio, E
Moratti, R
机构
[1] Univ Pavia, IRRCS Policlin San Matteo, Sez Anal Chim Clin, Dipartimento Biochim, I-27100 Pavia, Italy
[2] Osped Niguarda Ca Granda, Div Oncol Med Falck, Milan, Italy
[3] ESSECI Grp Srl, Milan, Italy
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2002年 / 774卷 / 01期
关键词
melatonin;
D O I
10.1016/S1570-0232(02)00168-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, sensitive and accurate method for the estimation of free and total (free plus protein-bound) melatonin (MLT) in human plasma and cerebrospinal fluid (CSF) is described. Via Chem-Elut cartridges, free and total MLT (the latter obtained after a deproteinization step) were quantified in dichloromethane-extracted samples and analyzed in one chromatographic run by high-performance liquid chromatography (HPLC) with fluorimetric detection, The column used was an Extrasil ODS-2 (3 mum, 150x4.6 mm I.D.), while the mobile phase consisted of 75 mM sodium acetate-acetonitrile (72:28, v/v) (pH 5.0). Repeatability and reproducibility of the method were 3.24 and 9.4%, respectively. The recovery of melatonin from plasma and CSF was 99.9+/-4.0% for non-deproteinized samples and 93.2+/-4.8% for deproteinized samples. The detection limit of the assay was 0.5 pg/ml. In human plasma, the mean+/-SD concentrations in the darkness period were 23.18+/-7.44 pg/ml for free melatonin and 82.5+/-36.48 pg/ml for total melatonin, while the lowest concentrations detected during daytime were 2.23+/-2.22 and 7.40+/-5.68 pg/ml, respectively. Detection of MLT in CSF was 5.01+/-2.31 and 28.55+/-6.95 pg/ml for the free and total fraction, respectively. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 23 条
[1]   RADIOIMMUNOASSAY OF MELATONIN - HUMAN-SERUM AND CEREBROSPINAL-FLUID [J].
ARENDT, J ;
WETTERBERG, L ;
HEYDEN, T ;
SIZONENKO, PC ;
PAUNIER, L .
HORMONE RESEARCH, 1977, 8 (02) :65-75
[2]   ENZYMATIC O-METHYLATION OF N-ACETYLSEROTONIN TO MELATONIN [J].
AXELROD, J ;
WEISSBACH, H .
SCIENCE, 1960, 131 (3409) :1312-1312
[3]   CIRCADIAN PATTERN OF PLASMA MELATONIN CONCENTRATIONS DURING 4 PHASES OF THE HUMAN MENSTRUAL-CYCLE [J].
BERGA, SL ;
YEN, SSC .
NEUROENDOCRINOLOGY, 1990, 51 (05) :606-612
[4]  
Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186
[5]   BINDING OF MELATONIN TO HUMAN AND RAT PLASMA-PROTEINS [J].
CARDINALI, DP ;
WURTMAN, RJ ;
LYNCH, HJ .
ENDOCRINOLOGY, 1972, 91 (05) :1213-+
[6]   HPLC validation of a circadian melatonin rhythm in the pineal gland of inbred mice [J].
Conti, A ;
Maestroni, GJM .
JOURNAL OF PINEAL RESEARCH, 1996, 20 (03) :138-144
[7]  
CRAFT CM, 1992, MELATONIN BIOSYNTHES, P17
[8]   Variable bioavailability of oral melatonin [J].
Di, WL ;
Kadva, A ;
Johnston, A ;
Silman, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :1028-1029
[9]  
Di WL, 1998, CLIN CHEM, V44, P304
[10]   Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia [J].
Hajak, G ;
Rodenbeck, A ;
Staedt, J ;
Bandelow, B ;
Huether, G ;
Ruther, E .
JOURNAL OF PINEAL RESEARCH, 1995, 19 (03) :116-122